{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:42:59Z","timestamp":1793378579975,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:00:00Z","timestamp":1625702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:00:00Z","timestamp":1625702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Estate of the Late Marion Alice Simpson"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Research on adherence interventions in rheumatology is limited by methodological issues, particularly heterogeneous outcomes. We aimed to describe researchers\u2019 experiences with conducting interventional studies targeting medication adherence in rheumatology and their perspectives on establishing core outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Semi-structured interviews using audio conference were conducted with researchers who had conducted an adherence study of any design in the past 10\u2009years. Data collection and thematic analysis were performed iteratively, until saturation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We interviewed 13 researchers, most of whom worked in academia and specialized in epidemiology and\/or health services research. We identified three themes: 1) improving measurement of adherence (considering all phases of adherence, using appropriate and relevant measures, and establishing clinically meaningful thresholds); 2) challenges in designing and appraising adherence intervention studies (considering the confusion over a plethora of outcomes, difficulties with powering studies to demonstrate meaningful changes, and suboptimal descriptions of adherence interventions in published studies); and 3) advancing outcome assessment in adherence intervention studies (capturing rationale for developing a core domain set as well as recommendations and anticipated challenges by participants).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Uniquely gathering perspectives from international adherence researchers, our findings led to researcher-informed recommendations for improving adherence research including specifying the targeted adherence phase in designing interventions and studies and providing a glossary of terms to promote consistency in reporting. We also identified recommendations for developing a core domain set for interventional studies targeting medication adherence including involvement of patients, clinicians, and other stakeholders and methodological and practical considerations to establish rigor and support uptake.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41927-021-00193-4","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T23:04:53Z","timestamp":1625699093000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Researchers\u2019 perspectives on methodological challenges and outcomes selection in interventional studies targeting medication adherence in rheumatic diseases: an OMERACT-adherence study"],"prefix":"10.1186","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1330-3388","authenticated-orcid":false,"given":"Shahrzad","family":"Salmasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3325-3840","authenticated-orcid":false,"given":"Ayano","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9755-2490","authenticated-orcid":false,"given":"Susan J.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8428-6354","authenticated-orcid":false,"given":"Maarten","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyn","family":"March","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Tugwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6340-8105","authenticated-orcid":false,"given":"Kathleen","family":"Tymms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6181-0646","authenticated-orcid":false,"given":"Suzanne","family":"Verstappen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2205-2683","authenticated-orcid":false,"given":"Mary A.","family":"De Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of the OMERACT-Adherence working group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,8]]},"reference":[{"issue":"10","key":"193_CR1","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/acr.22336","volume":"66","author":"MA De Vera","year":"2014","unstructured":"De Vera MA, Marcotte G, Rai S, et al. Medication adherence in gout: a systematic review. Arthritis Care Res. 2014;66(10):1551\u20139. https:\/\/doi.org\/10.1002\/acr.22336.","journal-title":"Arthritis Care Res"},{"issue":"11","key":"193_CR2","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1002\/acr.23191","volume":"69","author":"P Mehat","year":"2017","unstructured":"Mehat P, Atiquzzaman M, Esdaile JM, Avi\u00d1a-Zubieta A, de Vera MA. Medication non-adherence in systemic lupus Erythematosus: a systematic review. Arthritis Care Res. 2017;69(11):1706\u201313. https:\/\/doi.org\/10.1002\/acr.23191.","journal-title":"Arthritis Care Res"},{"issue":"7","key":"193_CR3","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1185\/03007990903017966","volume":"25","author":"R Halpern","year":"2009","unstructured":"Halpern R, Mody RR, Fuldeore MJ, Patel PA, Mikuls TR. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis. Curr Med Res Opin. 2009;25(7):1711\u20139. https:\/\/doi.org\/10.1185\/03007990903017966.","journal-title":"Curr Med Res Opin"},{"key":"193_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s13075-015-0801-4","volume":"17","author":"A Pasma","year":"2015","unstructured":"Pasma A, Schenk CV, Timman R, et al. Non-adherence to disease-modifying antirheumatic drugs is associated with higher disease activity in early arthritis patients in the first year of the disease. Arthritis Res Ther. 2015;17:281. https:\/\/doi.org\/10.1186\/s13075-015-0801-4.","journal-title":"Arthritis Res Ther"},{"key":"193_CR5","doi-asserted-by":"publisher","unstructured":"Salmasi S, Sayre EC, Avina-Zubieta JA, et al. Adherence to Antimalarial Therapy and Risk of Type 2 Diabetes Mellitus among Patients with Systemic Lupus Erythematosus: A Population-Based Study. n\/a. https:\/\/doi.org\/10.1002\/acr.24147.","DOI":"10.1002\/acr.24147"},{"issue":"12","key":"193_CR6","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1002\/acr.22636","volume":"67","author":"CH Feldman","year":"2015","unstructured":"Feldman CH, Yazdany J, Guan H, Solomon DH, Costenbader KH. Medication nonadherence is associated with increased subsequent acute care utilization among Medicaid beneficiaries with systemic lupus Erythematosus. Arthritis Care Res. 2015;67(12):1712\u201321. https:\/\/doi.org\/10.1002\/acr.22636.","journal-title":"Arthritis Care Res"},{"key":"193_CR7","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1136\/annrheumdis-2014-206593","volume":"75","author":"JS Galo","year":"2016","unstructured":"Galo JS, Mehat P, Rai SK, et al. What are the effects of medication adherence interventions in rheumatic diseases: a systematic review. Ann Rheumatic Dis. 2016;75:667\u201373. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206593.","journal-title":"Ann Rheumatic Dis"},{"key":"193_CR8","doi-asserted-by":"publisher","unstructured":"Kelly A, Crimston-Smith L, Tong A, et al. Scope of outcomes in trials and observational studies of interventions targeting medication adherence in rheumatic conditions: a systematic review. J Rheumatol. 2019: jrheum.190726. https:\/\/doi.org\/10.3899\/jrheum.190726.","DOI":"10.3899\/jrheum.190726"},{"key":"193_CR9","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13063-018-2565-z","volume":"19","author":"A Kelly","year":"2018","unstructured":"Kelly A, Tong A, Tymms K, et al. Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol. Trials. 2018;19:204. https:\/\/doi.org\/10.1186\/s13063-018-2565-z.","journal-title":"Trials"},{"key":"193_CR10","unstructured":"Initiative. O. Outcome Measures in Rheumatology. http:\/\/www.omeract.org. (Accessed 5th June 2020)."},{"key":"193_CR11","doi-asserted-by":"publisher","unstructured":"Knafl KA. Patton, M.Q. (1990). Qualitative evaluation and research methods (2nd ed.). Newbury Park, CA: Sage, 532 pp., $28.00 (hardcover). Res Nurs Health 1991; 14: 73-74. https:\/\/doi.org\/10.1002\/nur.4770140111.","DOI":"10.1002\/nur.4770140111"},{"issue":"2","key":"193_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101. https:\/\/doi.org\/10.1191\/1478088706qp063oa.","journal-title":"Qual Res Psychol"},{"key":"193_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.nedt.2003.10.001","volume":"24","author":"UH Graneheim","year":"2004","unstructured":"Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today. 2004;24:105\u201312. https:\/\/doi.org\/10.1016\/j.nedt.2003.10.001.","journal-title":"Nurse Educ Today"},{"issue":"1","key":"193_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/109019818401100101","volume":"11","author":"NK Janz","year":"1984","unstructured":"Janz NK, Becker MH. The health belief model: a decade later. Health Educ Q. 1984;11(1):1\u201347. https:\/\/doi.org\/10.1177\/109019818401100101.","journal-title":"Health Educ Q"},{"issue":"1","key":"193_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12160-013-9579-2","volume":"48","author":"LA Phillips","year":"2014","unstructured":"Phillips LA, Diefenbach M, Kronish IM, et al. The necessity-concerns-framework: a multidimensional theory benefits from multidimensional analysis. Ann Behav Med. 2014;48(1):7\u201316. https:\/\/doi.org\/10.1007\/s12160-013-9579-2.","journal-title":"Ann Behav Med"},{"key":"193_CR16","first-page":"3","volume-title":"Adherence to long-term therapies: Evidence for action","author":"World Health Organisation","year":"2003","unstructured":"World Health Organisation. Adherence to long-term therapies: Evidence for action. Geneva, Switzerland: WHO publications; 2003. p. 3\u20137."},{"key":"193_CR17","doi-asserted-by":"publisher","unstructured":"Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014:Cd000011. https:\/\/doi.org\/10.1002\/14651858.CD000011.pub4.","DOI":"10.1002\/14651858.CD000011.pub4"},{"issue":"2","key":"193_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4103\/tcmj.tcmj_177_18","volume":"31","author":"S Basu","year":"2019","unstructured":"Basu S, Garg S, Sharma N, Singh MM. Improving the assessment of medication adherence: challenges and considerations with a focus on low-resource settings. Ci Ji Yi Xue Za Zhi. 2019;31(2):73\u201380. https:\/\/doi.org\/10.4103\/tcmj.tcmj_177_18.","journal-title":"Ci Ji Yi Xue Za Zhi"},{"key":"193_CR19","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1097\/01.qai.0000248337.97814.66","volume":"43 Suppl 1","author":"KM Berg","year":"2006","unstructured":"Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquired Immune Defic Syndr. 2006;43 Suppl 1:S79\u201387. https:\/\/doi.org\/10.1097\/01.qai.0000248337.97814.66.","journal-title":"J Acquired Immune Defic Syndr"},{"key":"193_CR20","doi-asserted-by":"publisher","first-page":"217047","DOI":"10.1155\/2015\/217047","volume":"2015","author":"WY Lam","year":"2015","unstructured":"Lam WY, Fresco P. Medication Adherence Measures: An Overview. BioMed Res Int. 2015;2015:217047. https:\/\/doi.org\/10.1155\/2015\/217047.","journal-title":"BioMed Res Int"},{"key":"193_CR21","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/pds.4334","volume":"26","author":"WF Gellad","year":"2017","unstructured":"Gellad WF, Thorpe CT, Steiner JF, et al. The myths of medication adherence. Pharmacoepidemiol Drug Saf. 2017;26:1437\u201341. https:\/\/doi.org\/10.1002\/pds.4334.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"193_CR22","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1185\/03007990903126833","volume":"25","author":"S Karve","year":"2009","unstructured":"Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin. 2009;25(9):2303\u201310. https:\/\/doi.org\/10.1185\/03007990903126833.","journal-title":"Curr Med Res Opin"},{"key":"193_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","volume":"11","author":"JA Cramer","year":"2008","unstructured":"Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11:44\u20137. https:\/\/doi.org\/10.1111\/j.1524-4733.2007.00213.x.","journal-title":"Value Health"},{"key":"193_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.7326\/m18-0543","volume":"169","author":"S De Geest","year":"2018","unstructured":"De Geest S, Zullig LL, Dunbar-Jacob J, et al. ESPACOMP medication adherence reporting guideline (EMERGE). Ann Intern Med. 2018;169:30\u20135. https:\/\/doi.org\/10.7326\/m18-0543.","journal-title":"Ann Intern Med"},{"key":"193_CR25","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","volume":"73","author":"B Vrijens","year":"2012","unstructured":"Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73:691\u2013705. https:\/\/doi.org\/10.1111\/j.1365-2125.2012.04167.x.","journal-title":"Br J Clin Pharmacol"},{"key":"193_CR26","first-page":"Art 11","volume":"7","author":"R Opdenakker","year":"2006","unstructured":"Opdenakker R. Advantages and Disadvantages of Four Interview Techniques in Qualitative Research. Forum: Qualitative Social Research sozialforschung. 2006;7:Art 11 https:\/\/www.qualitative-research.net\/index.php\/fqs\/article\/view\/175\/392.","journal-title":"Forum: Qualitative Social Research sozialforschung"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-021-00193-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-021-00193-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-021-00193-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T23:07:56Z","timestamp":1625699276000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcrheumatol.biomedcentral.com\/articles\/10.1186\/s41927-021-00193-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,8]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["193"],"URL":"https:\/\/doi.org\/10.1186\/s41927-021-00193-4","relation":{},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,8]]},"assertion":[{"value":"21 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the University of British Columbia\u2019s review board.Written consent was obtained online from all participants through Qualtrics\u00ae.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}